Matches in Wikidata for { <http://www.wikidata.org/entity/Q90861349> ?p ?o ?g. }
Showing items 1 to 63 of
63
with 100 items per page.
- Q90861349 description "article scientifique publié en 2018" @default.
- Q90861349 description "artículu científicu espublizáu en xunetu de 2018" @default.
- Q90861349 description "im Juli 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q90861349 description "scientific article published on 23 July 2018" @default.
- Q90861349 description "wetenschappelijk artikel" @default.
- Q90861349 description "наукова стаття, опублікована в липні 2018" @default.
- Q90861349 name "Phase II study assessing the benefit of cisplatin re-introduction (stop-and-go strategy) in patients with advanced non-squamous non-small cell lung cancer: the IFCT-1102 BUCiL study (a Better Use of Cisplatin in Lung cancer)" @default.
- Q90861349 name "Phase II study assessing the benefit of cisplatin re-introduction (stop-and-go strategy) in patients with advanced non-squamous non-small cell lung cancer: the IFCT-1102 BUCiL study (a Better Use of Cisplatin in Lung cancer)" @default.
- Q90861349 type Item @default.
- Q90861349 label "Phase II study assessing the benefit of cisplatin re-introduction (stop-and-go strategy) in patients with advanced non-squamous non-small cell lung cancer: the IFCT-1102 BUCiL study (a Better Use of Cisplatin in Lung cancer)" @default.
- Q90861349 label "Phase II study assessing the benefit of cisplatin re-introduction (stop-and-go strategy) in patients with advanced non-squamous non-small cell lung cancer: the IFCT-1102 BUCiL study (a Better Use of Cisplatin in Lung cancer)" @default.
- Q90861349 prefLabel "Phase II study assessing the benefit of cisplatin re-introduction (stop-and-go strategy) in patients with advanced non-squamous non-small cell lung cancer: the IFCT-1102 BUCiL study (a Better Use of Cisplatin in Lung cancer)" @default.
- Q90861349 prefLabel "Phase II study assessing the benefit of cisplatin re-introduction (stop-and-go strategy) in patients with advanced non-squamous non-small cell lung cancer: the IFCT-1102 BUCiL study (a Better Use of Cisplatin in Lung cancer)" @default.
- Q90861349 P1433 Q90861349-F4A36EAF-2ED4-4E68-9A6B-7E1A82CE1E9F @default.
- Q90861349 P1476 Q90861349-E6F0E4EB-DB5E-40F0-863B-5D2201E97ED4 @default.
- Q90861349 P2093 Q90861349-2B0C5BCE-A7C9-497D-A201-9CF6850132E0 @default.
- Q90861349 P2093 Q90861349-3E70C6E2-D07F-4E37-A601-23B332C77BAC @default.
- Q90861349 P2093 Q90861349-52DC223F-B97A-4165-87D2-35BA07AFF336 @default.
- Q90861349 P2093 Q90861349-52E38EEB-FA3B-4FD7-B2AD-246FE18C2CBB @default.
- Q90861349 P2093 Q90861349-67CF5C77-5B33-484B-BE6C-7B1589D5D7F7 @default.
- Q90861349 P2093 Q90861349-879941BB-8CA4-43F1-AB66-A170B69EBA66 @default.
- Q90861349 P2093 Q90861349-8E40E75D-14D8-4BDD-B939-2E5EDB561457 @default.
- Q90861349 P2093 Q90861349-A56083F9-F825-45C8-B133-FB06F9967F2D @default.
- Q90861349 P2093 Q90861349-AB5BED10-A7E3-4089-9C33-D3413F864AC0 @default.
- Q90861349 P2093 Q90861349-C0DED67D-228B-4698-9EE5-604FD554F393 @default.
- Q90861349 P2093 Q90861349-DE159293-2DD1-4B91-9E91-2BFD48D5A840 @default.
- Q90861349 P2093 Q90861349-EB06B274-68F5-452B-9590-8CF4D8760A69 @default.
- Q90861349 P304 Q90861349-18EAFBD4-2FAD-4E63-953F-860C19987B66 @default.
- Q90861349 P31 Q90861349-DFF4DDE1-1FEE-4EB4-90A3-9E9613066081 @default.
- Q90861349 P356 Q90861349-D5D1CBCF-4689-4D26-A074-ACE0BDC81031 @default.
- Q90861349 P433 Q90861349-640E7836-9DE4-49FC-91A3-4F6AB489FE84 @default.
- Q90861349 P478 Q90861349-071F633A-0378-49AE-B186-F4EC91644DF4 @default.
- Q90861349 P50 Q90861349-5658F7C0-56A6-4147-A4D8-8735F04B1E4F @default.
- Q90861349 P577 Q90861349-06CB3984-C890-4E41-9333-0193815C1194 @default.
- Q90861349 P698 Q90861349-4F21DA39-A533-4543-82E1-09ECEF79333C @default.
- Q90861349 P921 Q90861349-BC12C379-A8AD-4ED7-9FC7-20B9B31CE03F @default.
- Q90861349 P932 Q90861349-943F525F-C147-4F75-B4FC-44DD5D16E882 @default.
- Q90861349 P356 ESMOOPEN-2018-000394 @default.
- Q90861349 P698 30094074 @default.
- Q90861349 P1433 Q53951848 @default.
- Q90861349 P1476 "Phase II study assessing the benefit of cisplatin re-introduction (stop-and-go strategy) in patients with advanced non-squamous non-small cell lung cancer: the IFCT-1102 BUCiL study (a Better Use of Cisplatin in Lung cancer)" @default.
- Q90861349 P2093 "Alexandra Langlais" @default.
- Q90861349 P2093 "Didier Debieuvre" @default.
- Q90861349 P2093 "Elisabeth Quoix" @default.
- Q90861349 P2093 "Fabrice Barlesi" @default.
- Q90861349 P2093 "Franck Morin" @default.
- Q90861349 P2093 "Jaafar Bennouna" @default.
- Q90861349 P2093 "Judith Raimbourg" @default.
- Q90861349 P2093 "Olivier Molinier" @default.
- Q90861349 P2093 "Pascal Do" @default.
- Q90861349 P2093 "Patrick Dumont" @default.
- Q90861349 P2093 "Pierre-Jean Souquet" @default.
- Q90861349 P2093 "Werner Hilgers" @default.
- Q90861349 P304 "e000394" @default.
- Q90861349 P31 Q13442814 @default.
- Q90861349 P356 "10.1136/ESMOOPEN-2018-000394" @default.
- Q90861349 P433 "5" @default.
- Q90861349 P478 "3" @default.
- Q90861349 P50 Q115583696 @default.
- Q90861349 P577 "2018-07-23T00:00:00Z" @default.
- Q90861349 P698 "30094074" @default.
- Q90861349 P921 Q412415 @default.
- Q90861349 P932 "6069905" @default.